VIVIMED LABS LTD. reported an audit qualification noting unrecognized interest on loans of approximately ₹453.34 million, leading to an understated loss of ₹443.82 million for FY 2024. Additionally, related party transactions lack external confirmations, impacting the accuracy of financial statements.